<?xml version="1.0" encoding="utf-8"?><Regulation lims:pit-date="2020-09-28" lims:lastAmendedDate="2020-09-28" lims:current-date="2020-11-17" lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261145" lims:id="1261145" gazette-part="II" regulation-type="SOR" xml:lang="en" xmlns:lims="http://justice.gc.ca/lims"><Identification lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261146" lims:id="1261146"><InstrumentNumber>SOR/2020-213</InstrumentNumber><RegistrationDate><Date><YYYY>2020</YYYY><MM>9</MM><DD>28</DD></Date></RegistrationDate><ConsolidationDate><Date><YYYY>2020</YYYY><MM>11</MM><DD>18</DD></Date></ConsolidationDate><EnablingAuthority lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261147" lims:id="1261147"><XRefExternal reference-type="act" link="F-27">FOOD AND DRUGS ACT</XRefExternal></EnablingAuthority><LongTitle lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261148" lims:id="1261148">Establishment Licence Fees Remission Order (Indication of an Activity in respect of a COVID-19 Drug)</LongTitle></Identification><Order lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261149" lims:id="1261149"><Provision lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261150" lims:id="1261150" format-ref="indent-0-0" language-align="yes"><Text>The Minister of Health, pursuant to section 30.63<FootnoteRef idref="fn_81200-2-539_hq_27237">a</FootnoteRef> of the <XRefExternal reference-type="act" link="F-27">Food and Drugs Act</XRefExternal><FootnoteRef idref="fn_81200-2-539_hq_27238">b</FootnoteRef>, makes the annexed <XRefExternal reference-type="regulation">Establishment Licence Fees Remission Order (Indication of an Activity in respect of a COVID-19 Drug)</XRefExternal>.</Text></Provision><Provision lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261151" lims:id="1261151" format-ref="indent-0-0" language-align="yes"><Text>Ottawa, September 16, 2020</Text><SignatureBlock justification="left" width="20pc"><SignatureName justification="left" topmarginspacing="12">Patricia A. Hajdu</SignatureName><SignatureTitle justification="left">Minister of Health</SignatureTitle></SignatureBlock></Provision><Footnote id="fn_81200-2-539_hq_27237" placement="page" status="official"><Label>a</Label><Text>S.C. 2017, c. 20, s. 317</Text></Footnote><Footnote id="fn_81200-2-539_hq_27238" placement="page" status="official"><Label>b</Label><Text>R.S., c. F-27</Text></Footnote></Order><Body lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261152" lims:id="1261152"><Heading lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261153" lims:id="1261153" level="1"><TitleText>Interpretation</TitleText></Heading><Section lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:lastAmendedDate="2020-09-28" lims:fid="1261154" lims:id="1261154"><MarginalNote lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261155" lims:id="1261155">Definitions</MarginalNote><Label>1</Label><Subsection lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261156" lims:id="1261156"><Label>(1)</Label><Text>The following definitions apply in this Order.</Text><Definition lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261157" lims:id="1261157"><Text><DefinedTermEn>activity</DefinedTermEn> means an activity set out in Table I to section C.01A.008 of the Regulations. (<DefinedTermFr>activité</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261158" lims:id="1261158"><Text><DefinedTermEn>COVID-19</DefinedTermEn> means the coronavirus disease 2019. (<DefinedTermFr>COVID-19</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261159" lims:id="1261159"><Text><DefinedTermEn>COVID-19 drug</DefinedTermEn> means a drug that is manufactured, sold or represented for use in relation to COVID-19. (<DefinedTermFr>drogue contre la COVID-19</DefinedTermFr>)</Text></Definition><Definition lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261160" lims:id="1261160"><Text><DefinedTermEn>drug</DefinedTermEn> means a drug other than</Text><Paragraph lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261161" lims:id="1261161"><Label>(a)</Label><Text>a veterinary health product; or</Text></Paragraph><Paragraph lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261162" lims:id="1261162"><Label>(b)</Label><Text>a <DefinitionRef>natural health product</DefinitionRef> as defined in subsection 1(1) of the <XRefExternal reference-type="regulation" link="SOR-2003-196">Natural Health Products Regulations</XRefExternal>. (<DefinedTermFr>drogue</DefinedTermFr>)</Text></Paragraph></Definition><Definition lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261163" lims:id="1261163"><Text><DefinedTermEn>Regulations</DefinedTermEn> means the <XRefExternal reference-type="regulation" link="C.R.C.,_c._870">Food and Drug Regulations</XRefExternal>. (<DefinedTermFr>Règlement</DefinedTermFr>)</Text></Definition></Subsection><Subsection lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261164" lims:id="1261164"><MarginalNote lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261165" lims:id="1261165">Other words and expressions</MarginalNote><Label>(2)</Label><Text>Unless the context otherwise requires, words and expressions used in this Order have the meanings assigned by the Regulations or the <XRefExternal reference-type="regulation" link="SOR-2019-124">Fees in Respect of Drugs and Medical Devices Order</XRefExternal>, as the case may be.</Text></Subsection></Section><Heading lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261166" lims:id="1261166" level="1"><TitleText>Remissions</TitleText></Heading><Section lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:lastAmendedDate="2020-09-28" lims:fid="1261167" lims:id="1261167"><MarginalNote lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261168" lims:id="1261168">Establishment licence</MarginalNote><Label>2</Label><Subsection lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261169" lims:id="1261169"><Label>(1)</Label><Text>Subject to subsection (2), remission of an amount equal to the fee referred to in subsection 29(1) of the <XRefExternal reference-type="regulation" link="SOR-2019-124">Fees in Respect of Drugs and Medical Devices Order</XRefExternal> for the examination of one of the following applications or, if applicable, of the amount referred to in section 49 of that Order is granted to a person described in subsection 29(2) of that Order:</Text><Paragraph lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261170" lims:id="1261170"><Label>(a)</Label><Text>an application for an establishment licence referred to in subsection 20(1) of the <XRefExternal reference-type="regulation">Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to COVID-19</XRefExternal> that includes a statement to the effect that the application relates solely to activities in respect of a COVID-19 drug; or</Text></Paragraph><Paragraph lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261171" lims:id="1261171"><Label>(b)</Label><Text>an application for the amendment of an establishment licence referred to in subsection 20(2) of that Interim Order that includes such a statement.</Text></Paragraph></Subsection><Subsection lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261172" lims:id="1261172"><MarginalNote lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261173" lims:id="1261173">Conditions</MarginalNote><Label>(2)</Label><Text>The remission is granted on the condition that</Text><Paragraph lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261174" lims:id="1261174"><Label>(a)</Label><Text>in the case of an application for an establishment licence in respect of a building located in Canada or for the amendment of an establishment licence to add a building located in Canada, each activity specified in the application that is proposed to be conducted in the building will be conducted solely in respect of a COVID-19 drug; and</Text></Paragraph><Paragraph lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261175" lims:id="1261175"><Label>(b)</Label><Text>the person who submits the application provides the Minister, on written request, with documents that demonstrate that each activity specified in the application and conducted in the building is conducted solely in respect of a COVID-19 drug.</Text></Paragraph></Subsection></Section><Section lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:lastAmendedDate="2020-09-28" lims:fid="1261176" lims:id="1261176"><MarginalNote lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261177" lims:id="1261177">Annual review</MarginalNote><Label>3</Label><Subsection lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261178" lims:id="1261178"><Label>(1)</Label><Text>Subject to subsection (4), remission is granted of the amounts referred to in subsections (2) and (3) to the person described in subsection 29(2) of the <XRefExternal reference-type="regulation" link="SOR-2019-124">Fees in Respect of Drugs and Medical Devices Order</XRefExternal> that submits an application for the annual review of an establishment licence that was issued or amended by the Minister under section C.01A.008 of the Regulations after examination of an application referred to in paragraph 2(1)(a) or (b), as the case may be.</Text></Subsection><Subsection lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261179" lims:id="1261179"><MarginalNote lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261180" lims:id="1261180">Amount — building located in Canada</MarginalNote><Label>(2)</Label><Text>The amount that is remitted in respect of each building located in Canada is</Text><Paragraph lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261181" lims:id="1261181"><Label>(a)</Label><Text>in the case of an establishment licence issued by the Minister under section C.01A.008 of the Regulations after examination of an application referred to in paragraph 2(1)(a) and, if applicable, amended only after examination of an application referred to in paragraph 2(1)(b), an amount equal to the fee referred to in subsection 29(1) of the <XRefExternal reference-type="regulation" link="SOR-2019-124">Fees in Respect of Drugs and Medical Devices Order</XRefExternal> for the examination of the application for the annual review of the establishment licence or, if applicable, the amount referred to in section 49 of that Order; or</Text></Paragraph><Paragraph lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261182" lims:id="1261182"><Label>(b)</Label><Text>in the case of one of the following amended establishment licences, an amount equal to the difference between the fee referred to in subsection 29(1) of the <XRefExternal reference-type="regulation" link="SOR-2019-124">Fees in Respect of Drugs and Medical Devices Order</XRefExternal> for the examination of the application for the annual review of the establishment licence that would be payable if the activities conducted in respect of any COVID-19 drug were the only activities specified in the licence or, if applicable, the amount referred to in section 49 of that Order and the fee that would be payable if the activities conducted in respect of any other drug were the only activities specified in the licence, if the fee that would be payable for the activities conducted in respect of any COVID-19 drug is higher than the fee that would be payable for the activities conducted in respect of any other drug</Text><Subparagraph lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261183" lims:id="1261183"><Label>(i)</Label><Text>an establishment licence issued by the Minister under section C.01A.008 of the Regulations after examination of an application referred to in paragraph 2(1)(a) and amended after examination of an application other than one referred to in paragraph 2(1)(b), or</Text></Subparagraph><Subparagraph lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261184" lims:id="1261184"><Label>(ii)</Label><Text>an establishment licence issued by the Minister under section C.01A.008 of the Regulations after examination of an application other than one referred to in paragraph 2(1)(a) and amended after examination of an application referred to in paragraph 2(1)(b).</Text></Subparagraph></Paragraph></Subsection><Subsection lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261185" lims:id="1261185"><MarginalNote lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261186" lims:id="1261186">Amount — building located outside Canada</MarginalNote><Label>(3)</Label><Text>The amount that is remitted in respect of each building located outside Canada is an amount equal to the fee referred to in section 40 of the <XRefExternal reference-type="regulation" link="SOR-2019-124">Fees in Respect of Drugs and Medical Devices Order</XRefExternal> for the examination of an application for the annual review of an establishment licence that was issued by the Minister under section C.01A.008 of the Regulations after examination of an application referred to in paragraph 2(1)(a) or (b) or, if applicable, the amount referred to in section 49 of that Order.</Text></Subsection><Subsection lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261187" lims:id="1261187"><MarginalNote lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261188" lims:id="1261188">Conditions</MarginalNote><Label>(4)</Label><Text>The remission is granted on the condition that</Text><Paragraph lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261189" lims:id="1261189"><Label>(a)</Label><Text>each activity specified in an application referred to in paragraph 2(2)(a) that is conducted in the building listed on the establishment licence is conducted solely in respect of a COVID-19 drug;</Text></Paragraph><Paragraph lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261190" lims:id="1261190"><Label>(b)</Label><Text>each activity that is conducted in the building referred to in subsection (3) for the person who submits the application for the annual licence review is conducted solely in respect of a COVID-19 drug;</Text></Paragraph><Paragraph lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261191" lims:id="1261191"><Label>(c)</Label><Text>the person who submits the application provides the Minister, on written request, with documents that demonstrate that the conditions set out in paragraphs (a) and (b) are met; and</Text></Paragraph><Paragraph lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261192" lims:id="1261192"><Label>(d)</Label><Text>the Minister has not, under section C.01A.008 of the Regulations, issued another establishment licence or amended the establishment licence referred to in subsection (1) after examination of an application that contains the same documents and information as an application referred to in paragraph 2(1)(a) or (b), as the case may be, but that does not include the statement referred to in that paragraph.</Text></Paragraph></Subsection></Section><Heading lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261193" lims:id="1261193" level="1"><TitleText>Coming into Force</TitleText></Heading><Section lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:lastAmendedDate="2020-09-28" lims:fid="1261194" lims:id="1261194" type="CIFnobold"><MarginalNote lims:inforce-start-date="2020-09-28" lims:enacted-date="2020-09-28" lims:fid="1261195" lims:id="1261195">Registration</MarginalNote><Label>4</Label><Text>This Order comes into force on the day on which it is registered.</Text></Section></Body></Regulation>